ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,387,000 | +37.1% | 13,872 | 0.0% | 0.07% | +67.5% |
| Q2 2021 | $1,741,000 | -7.4% | 13,872 | 0.0% | 0.04% | -4.8% |
| Q1 2021 | $1,881,000 | +6.0% | 13,872 | 0.0% | 0.04% | +2.4% |
| Q4 2020 | $1,775,000 | +13.7% | 13,872 | 0.0% | 0.04% | +5.1% |
| Q3 2020 | $1,561,000 | -17.2% | 13,872 | -29.9% | 0.04% | -9.3% |
| Q2 2020 | $1,886,000 | -8.3% | 19,800 | -13.5% | 0.04% | -17.3% |
| Q1 2020 | $2,057,000 | -24.7% | 22,887 | -55.5% | 0.05% | -3.7% |
| Q4 2019 | $2,730,000 | +34.2% | 51,489 | 0.0% | 0.05% | +17.4% |
| Q3 2019 | $2,034,000 | -3.8% | 51,489 | 0.0% | 0.05% | -8.0% |
| Q2 2019 | $2,115,000 | -11.8% | 51,489 | 0.0% | 0.05% | -10.7% |
| Q1 2019 | $2,398,000 | +7.0% | 51,489 | 0.0% | 0.06% | -26.3% |
| Q4 2018 | $2,242,000 | -23.9% | 51,489 | 0.0% | 0.08% | -9.5% |
| Q3 2018 | $2,947,000 | +3.8% | 51,489 | -12.0% | 0.08% | +25.4% |
| Q2 2018 | $2,838,000 | +24.1% | 58,500 | 0.0% | 0.07% | +4.7% |
| Q1 2018 | $2,287,000 | -7.9% | 58,500 | 0.0% | 0.06% | -3.0% |
| Q4 2017 | $2,482,000 | +13.7% | 58,500 | 0.0% | 0.07% | +20.0% |
| Q3 2017 | $2,183,000 | +4.2% | 58,500 | -15.2% | 0.06% | -3.5% |
| Q2 2017 | $2,096,000 | +81.6% | 69,000 | +58.3% | 0.06% | +78.1% |
| Q1 2017 | $1,154,000 | – | 43,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |